Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eksp Klin Farmakol ; 61(1): 51-3, 1998.
Artigo em Russo | MEDLINE | ID: mdl-9575413

RESUMO

The antiviral activity of iodantipyrine was studied in outbred [correction of inbred] albino mice (weight 10-12 g) infected with the Absettarov strain of the tick-borne encephalitis virus. Iodantipyrine was administered per os or parenterally and the animals were observed for 21 days. A reliable therapeutic effect was produced in 60% of mice infected with 10 DL50 of tick-borne encephalitis virus which were given the drug per os in a dose of 50 mg/kg. Preventive administration of the drug was effective in 47% of the animals.


Assuntos
Antipirina/análogos & derivados , Antivirais/administração & dosagem , Encefalite Transmitida por Carrapatos/tratamento farmacológico , Animais , Antipirina/administração & dosagem , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Encefalite Transmitida por Carrapatos/mortalidade , Encefalite Transmitida por Carrapatos/prevenção & controle , Camundongos , Tilorona/administração & dosagem , Fatores de Tempo
2.
Vopr Virusol ; 39(3): 136-8, 1994.
Artigo em Russo | MEDLINE | ID: mdl-8091756

RESUMO

The antiviral activity of iodantipyrine-4 belonging to the group of nonsteroid anti-inflammatory compounds was studied in inbred white mice of 10-12 g given a single subcutaneous injection of the Absettarov strain of tick-borne encephalitis virus. Iodantipyrine-4 in different doses was administered orally or parenterally, and the animals were observed for 21 days. In the group of mice infected with 10 LD50 of TBE virus which were treated with the drug orally in a dose of 50 mg/kg a reliable therapeutic effect was established in 60%, after parenteral injection in 53.4%. Prophylactic administration of the drug followed by challenge with 10 LD50 of virus was effective in 47% of mice. In the group of mice infected with 100 LD50 of the virus the therapeutic effect was observed in 38% and prophylactic in 30%. Iodantipyrine-4 was found to induce interferon production.


Assuntos
Anti-Inflamatórios não Esteroides/uso terapêutico , Antipirina/análogos & derivados , Antivirais/uso terapêutico , Encefalite Transmitida por Carrapatos/tratamento farmacológico , Administração Oral , Animais , Anti-Inflamatórios não Esteroides/administração & dosagem , Antipirina/administração & dosagem , Antipirina/uso terapêutico , Antivirais/administração & dosagem , Dipiridamol/administração & dosagem , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Encefalite Transmitida por Carrapatos/sangue , Encefalite Transmitida por Carrapatos/prevenção & controle , Injeções Intraperitoneais , Indutores de Interferon/administração & dosagem , Indutores de Interferon/uso terapêutico , Interferon-alfa/sangue , Masculino , Camundongos
7.
Vopr Virusol ; 28(4): 50-3, 1983.
Artigo em Russo | MEDLINE | ID: mdl-6314669

RESUMO

The main molecular biology parameters of an attenuated mutant DMS-20/6 of eastern equine encephalomyelitis virus derived by treatment with dimethylsulphate of the wild type virus (strain No. 627) were determined. The sedimentation coefficient of sucrose density gradient purified and concentrated virus was 280 S, the buoyant density of virions in sucrose density gradient was 1.19 g/cm3. The DMS-20/6 virion had 3 proteins with molecular weights of 56, 50, and 34 kilodaltons, and the size of virions by negative staining was 58-77 nm.


Assuntos
Alphavirus/análise , Vírus da Encefalite Equina do Leste/análise , Mutação , Centrifugação Zonal , Dimetil Sulfóxido/farmacologia , Eletroforese em Gel de Poliacrilamida , Vírus da Encefalite Equina do Leste/efeitos dos fármacos , Vírus da Encefalite Equina do Leste/isolamento & purificação , Microscopia Eletrônica , Proteínas Virais/análise , Proteínas Virais/isolamento & purificação , Vírion/análise , Vírion/efeitos dos fármacos , Vírion/isolamento & purificação , Virulência/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...